Yong Gao

Years Active: 2020-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Naihua Liu, Xiaoying Yang, Jingyi Guo, Lei Zhang, Shangyi Huang, Jiabing Chen, Jiawen Huang, Yingjian Chen, Tianqi Cui, Yi Zheng, Tianyao Li, Kaijia Tang, Yadi Zhong, Siwei Duan, Lili Yu, Ying Tang, Dayong Zheng, Huafeng Pan, Yong Gao
Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis. EMBO reports (2023)
Nannan Sun, Chuangpeng Shen, Lei Zhang, Xiaojie Wu, Yuanyuan Yu, Xiaoying Yang, Chen Yang, Chong Zhong, Zhao Gao, Wei Miao, Zehong Yang, Weihang Gao, Ling Hu, Kevin Williams, Changhui Liu, Yongsheng Chang, Yong Gao
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. Gut 70 (11) (2020)

Yong Gao.css-eqlu8i{font-size:small;padding-left:4px;}